Trial · NCT03201445
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percentage of Participants With a ≥ 50% Decrease From Baseline in Sperm Concentration at Week 13 | Baseline to Week 13 | The Semen Analysis Set included all randomized and treated (≥ 1 dose of double-blind study drug) participants who had 2 semen samples that were eligible for mean calculation at baseline and at the Week 13 analysis visit with the date of the first chronologic semen sample used for purposes of assigning analysis visit windows. | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants With a ≥ 50% Decrease From Baseline in Sperm Concentration at Week 26 | Baseline to Week 26 | Participants in the Week 26 Semen Analysis Set (included all participants who took ≥ 1 dose of study drug and had 2 evaluable samples at baseline and at ≥ 1 postbaseline measurement at/after Week 26 or OL Week 13) with available data were analyzed. | percentage of participants | NUMBER |
| SECONDARY | Change From Baseline in Sperm Total Motility at Week 13 | Baseline, Week 13 | Participants in the Semen Analysis Set were analyzed. | percentage of motile sperms | MEDIAN |
| SECONDARY | Change From Baseline in Sperm Total Motility at Week 26 | Baseline, Week 26 | Participants in the Week 26 Semen Analysis Set with available data were analyzed. | percentage of motile sperms | MEDIAN |
| SECONDARY | Change From Baseline in Total Sperm Count at Week 13 | Baseline, Week 13 | Participants in the Semen Analysis Set were analyzed. | million sperm cells/ejaculate | MEDIAN |
| SECONDARY | Change From Baseline in Total Sperm Count at Week 26 | Baseline, Week 26 | Participants in the Week 26 Semen Analysis Set with available data were analyzed. | million sperm cells/ejaculate | MEDIAN |
| SECONDARY | Change From Baseline in Sperm Concentration at Week 13 | Baseline, Week 13 | Participants in the Semen Analysis Set were analyzed. | million sperm cells/mL | MEDIAN |
| SECONDARY | Change From Baseline in Sperm Concentration at Week 26 | Baseline, Week 26 | Participants in the Week 26 Semen Analysis Set with available data were analyzed. | million sperm cells/mL | MEDIAN |
| SECONDARY | Change From Baseline in Ejaculate Volume at Week 13 | Baseline, Week 13 | Participants in the Semen Analysis Set were analyzed. | mL | MEDIAN |
| SECONDARY | Change From Baseline in Ejaculate Volume at Week 26 | Baseline, Week 26 | Participants in the Week 26 Semen Analysis Set with available data were analyzed. | mL | MEDIAN |
| SECONDARY | Change From Baseline in Percent Normal Sperm Morphology at Week 13 | Baseline, Week 13 | Participants in the Semen Analysis Set were analyzed. | percentage of normal sperms | MEDIAN |
| SECONDARY | Change From Baseline in Percent Normal Sperm Morphology at Week 26 | Baseline, Week 26 | Participants in the Week 26 Semen Analysis Set with available data were analyzed. | percentage of normal sperms | MEDIAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03201445/outcomes